Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biostandard is a South Korean biotechnology company specializing in the development and manufacture of hyaluronic acid (HA) based medical devices and aesthetic products. The company is best known for its Meline line of dermal fillers and its Adheseal anti-adhesion barrier used in surgical procedures. Biostandard leverages proprietary cross-linking technologies to produce high-quality biomaterials for the global aesthetics and regenerative medicine markets. Their portfolio includes various formulations of fillers, adhesion barriers, and other tissue engineering solutions. The company maintains a strong focus on R&D to improve the safety and longevity of its biocompatible products. Biostandard has expanded its reach internationally, obtaining CE certification for its core product lines to facilitate global distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biostandard.